GC

GSP Crop Science Ltd

Q2 FY27Fertilizers & Agrochemicals

GSP Crop Science Q2 Results 2026: PAT ₹45 Cr, Revenue ₹558 Cr

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹558Cr
Net profit
₹45Cr
Margin
13.2%

Based on GSP Crop Science Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹439
Market cap₹2.0K Cr
P/E19.5

The short version

Revenue from operations in Q2 FY27 was ₹5,584 Mn, up 19.5% year-on-year from ₹4,673 Mn in Q2 FY26 (Page 15). EBITDA for Q2 FY27: ₹1,161 Mn, down 14.3% YoY.

From GSP Crop Science Ltd's Q2 FY27 earnings-call transcript · updated 13 Nov 2026.

How did GSP Crop Science's revenue grow in the September 2026 quarter?

  • Revenue from operations in Q2 FY27 was ₹5,584 Mn, up 19.5% year-on-year from ₹4,673 Mn in Q2 FY26 (Page 15).
  • H1 FY27 revenue was ₹9,444 Mn, a 11.9% increase year-on-year (Page 15).
  • The presentation notes export business revenue growth of +20% over last year, driven by sales in Brazil, USA, and Africa (Page 11).

2 more points from GSP Crop Science Ltd's call on revenue

Create a free account to keep reading this call

What happened to GSP Crop Science's margins in Q2 FY27?

EBITDA for Q2 FY27: ₹1,161 Mn, down 14.3% YoY

Locked: what GSP Crop Science Ltd said on margins

Also locked on this page: fundraising, order book

Free account, 30 seconds. No card needed.

What capex is GSP Crop Science planning?

  • New intermediate manufacturing plant set up at Saykha, Gujarat (2026) through subsidiary GSP Intermediates Pvt. Ltd., now wholly-owned.
  • Kathwada Facility commissioned formulation R&D pilot plant (capacity 6,000 MT) in 2022.
  • Existing manufacturing capacities:
  • Odhav Facility: Formulations - 27,132 MT, Technicals - 3,960 MT
  • Kathwada Facility: Formulations - 6,000 MT
  • Nandesari Facility: Technicals - 11,160 MT
  • Samba Facility: Formulations - 10,540 MT

2 more points from GSP Crop Science Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is GSP Crop Science raising money or cutting debt?

The presentation mentions reducing debt by ₹2,200 Mn from IPO proceeds to strengthen the balance sheet and…

Locked: what GSP Crop Science Ltd said on fundraising

Also locked on this page: margins, order book

Free account, 30 seconds. No card needed.

How big is GSP Crop Science's order book?

See what GSP Crop Science Ltd said on order book & pipeline — free account, 30 seconds.

GSP Crop Science Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27

Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the table below.

GSP Crop Science Ltd Q2 FY27 results — key figures

GSP Crop Science Ltd Q2 FY27 reported results vs year-ago quarter, ₹ crore
₹ CrQ2 FY27
Revenue558
Operating profit (EBITDA)74
Operating margin13.2%
Profit before tax60
Net profit (PAT)45
EPS (₹)9.60

Source: GSP Crop Science Ltd's results filing to NSE (consolidated), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹386 Cr, net profit ₹26 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

More Q2 FY27 results in Fertilizers & Agrochemicals

All Q2 FY27 results | Fertilizers & Agrochemicals rankings

What GSP Crop Science's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

  • Balaji Phosphates (Q2 FY27)

    Year-on-year growth for the half year (Standalone): ~31.4% increase (from Rs. Key results statement takeaways from Balaji Phosphates Ltd's Q2 FY27 results state

  • Bohra Industries (Q2 FY27)

    Revenue from Operations for the quarter ended 30th September 2026: Nil (₹0.00 lakhs). Key results statement takeaways from Bohra Industries Ltd's Q2 FY27 result

  • Aries Agro (Q2 FY27)

    Revenue from Operations (Consolidated) for Q2 (30-Sep-26) is ₹29,604.09 lakhs, compared to ₹25,045.01 lakhs in Q2 the previous year, showing a year-on-year…

  • Rama Phosphates (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹29,551 Lacs . Key investor presentation takeaways from Rama Phosphates Ltd's Q2 FY27 investor presentation — and how it ranks

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

GSP Crop Science Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were GSP Crop Science Ltd Q2 FY27 results?

Revenue from operations in Q2 FY27 was ₹5,584 Mn, up 19.5% year-on-year from ₹4,673 Mn in Q2 FY26 (Page 15). EBITDA for Q2 FY27: ₹1,161 Mn, down 14.3% YoY.

What is GSP Crop Science Ltd share price analysis?

GSP Crop Science Ltd currently shows a neutral. The stock trades at a P/E of 19.5 with a market cap of ₹2,042 Cr. Investors should review the full earnings analysis for detailed insights.

Is GSP Crop Science Ltd planning capital expenditure?

New intermediate manufacturing plant set up at Saykha, Gujarat (2026) through subsidiary GSP Intermediates Pvt.

Keep GSP Crop Science Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.